When it comes to liver oncology, silencing of ANXA2 arrested the cell cycle in vitro, inhibited tumor growth in vivo [94], and suppressed the invasion, migration, and tumorigenic potential of HCC cells [93]. This evidence concerns the gene ANXA2 and neoplasm.